Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What information is available on company profile pages?

Company profile pages provide comprehensive information including financial statements, earnings data, analyst ratings, institutional ownership, insider trading, SEC filings, and detailed business analysis.

How do I analyze a company's financial health?

Use our financial metrics including P/E ratio, debt-to-equity, revenue growth, profit margins, and cash flow analysis to evaluate a company's financial strength and growth potential.

How do I analyze EBS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate EBS investment potential.

What is EBS stock price today?

The current EBS stock price is $12.63 as of 27 Dec '25. Get real-time EBS stock price, historical data, and price charts on Financhill.

Is EBS a good investment?

Evaluate EBS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

What does Emergent BioSolutions, Inc. (EBS) do?

Emergent BioSolutions, Inc. (EBS) is a publicly traded company. View detailed company information, business model, financial statements, and corporate data on our EBS company profile page.

How to buy EBS stock?

To buy EBS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of EBS?

View detailed market capitalization data and company valuation metrics for EBS on our comprehensive analysis page.

What is the P/E ratio of EBS?

Use our fundamental analysis tools to view EBS P/E ratio and compare valuation metrics with industry peers.

What are EBS earnings?

View EBS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Buy

70

EBS Quote, Financials, Valuation and Earnings

Last price:

$12.43

Seasonality move :

-2.41%

Day range:

$12.51 - $12.86

52-week range:

$4.02 - $13.41

Dividend yield:

0%

P/E ratio:

9.76x

P/S ratio:

0.89x

P/B ratio:

1.14x

Volume:

322K

Avg. volume:

851.7K

1-year change:

52.17%

Market cap:

$663.3M

Revenue:

$1B

EPS (TTM):

$1.29

Emergent BioSolutions, Inc. SEC Filings

Company	Filed	Form Type	Description
EBS Emergent BioSolutions, Inc.	05/02/2024	10-Q	10-Q filing on 05/02/2024	View Form
EBS Emergent BioSolutions, Inc.	12/11/2023	10-Q	10-Q filing on 12/11/2023	View Form
EBS Emergent BioSolutions, Inc.	08/09/2023	10-Q	10-Q filing on 08/09/2023	View Form
EBS Emergent BioSolutions, Inc.	05/10/2023	10-Q	10-Q filing on 05/10/2023	View Form
EBS Emergent BioSolutions, Inc.	11/09/2022	10-Q	10-Q filing on 11/09/2022	View Form
EBS Emergent BioSolutions, Inc.	08/02/2022	10-Q	10-Q filing on 08/02/2022	View Form
EBS Emergent BioSolutions, Inc.	04/29/2022	10-Q	10-Q filing on 04/29/2022	View Form
EBS Emergent BioSolutions, Inc.	11/05/2021	10-Q	10-Q filing on 11/05/2021	View Form
EBS Emergent BioSolutions, Inc.	07/30/2021	10-Q	10-Q filing on 07/30/2021	View Form
EBS Emergent BioSolutions, Inc.	04/30/2021	10-Q	10-Q filing on 04/30/2021	View Form
EBS Emergent BioSolutions, Inc.	11/06/2020	10-Q	10-Q filing on 11/06/2020	View Form
EBS Emergent BioSolutions, Inc.	07/31/2020	10-Q	10-Q filing on 07/31/2020	View Form
EBS Emergent BioSolutions, Inc.	05/01/2020	10-Q	10-Q filing on 05/01/2020	View Form
EBS Emergent BioSolutions, Inc.	02/25/2020	10-K	10-K filing on 02/25/2020	View Form
EBS Emergent BioSolutions, Inc.	11/07/2019	10-Q	10-Q filing on 11/07/2019	View Form
EBS Emergent BioSolutions, Inc.	08/02/2019	10-Q	10-Q filing on 08/02/2019	View Form
EBS Emergent BioSolutions, Inc.	05/08/2019	10-Q	10-Q filing on 05/08/2019	View Form
EBS Emergent BioSolutions, Inc.	02/22/2019	10-K	10-K filing on 02/22/2019	View Form
EBS Emergent BioSolutions, Inc.	11/02/2018	10-Q	10-Q filing on 11/02/2018	View Form
EBS Emergent BioSolutions, Inc.	08/03/2018	10-Q	10-Q filing on 08/03/2018	View Form
EBS Emergent BioSolutions, Inc.	05/04/2018	10-Q	10-Q filing on 05/04/2018	View Form
EBS Emergent BioSolutions, Inc.	02/23/2018	10-K	10-K filing on 02/23/2018	View Form
EBS Emergent BioSolutions, Inc.	11/03/2017	10-Q	10-Q filing on 11/03/2017	View Form
EBS Emergent BioSolutions, Inc.	08/04/2017	10-Q	10-Q filing on 08/04/2017	View Form
EBS Emergent BioSolutions, Inc.	05/05/2017	10-Q	10-Q filing on 05/05/2017	View Form
EBS Emergent BioSolutions, Inc.	02/28/2017	10-K	10-K filing on 02/28/2017	View Form
EBS Emergent BioSolutions, Inc.	11/09/2016	10-Q	10-Q filing on 11/09/2016	View Form
EBS Emergent BioSolutions, Inc.	08/05/2016	10-Q	10-Q filing on 08/05/2016	View Form
EBS Emergent BioSolutions, Inc.	05/06/2016	10-Q	10-Q filing on 05/06/2016	View Form
EBS Emergent BioSolutions, Inc.	02/29/2016	10-K	10-K filing on 02/29/2016	View Form

Related Companies

Get EBS Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

EBS

Sector

P/E ratio

9.76x

23.89x

PEG ratio

-0.01x

P/B ratio

1.14x

1.82x

Price / LTM sales

0.89x

1.60x

Growth Metrics

EBS

Sector

Revenue growth

-21.34%

4.62%

Earnings growth

-56.11%

10.88%

Revenue (5-year growth)

-1.16%

6.5%

Earnings forecast

-$0.12

-$0.21

Profitability

EBS

Sector

Profitability FY 2024

$305.2M

$3.5M

Return on invested capital

6.29%

-31.77%

Return on assets

5.29%

-27.96%

Return on equity

14.25%

-37.63%

Earnings Date

Last Earnings Date

Oct

29

Next Earnings Date

Mar

4

Estimated Next Earnings Date

Jan

28

Balance Sheet

EBS

Sector

Total cash

$249.2M

$26.3M

Short term investments

--

$25.7M

Total assets

$1.4B

$78M

Long term debt

$669.2M

$3.3M

Stock Ideas

Buy

57

Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy or Sell?

Buy

55

Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy or Sell?

Buy

61

Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Buy or Sell?

Alerts

Buy

64

GLTO alert for Dec 26

Galecto, Inc. [GLTO] is up 16.92% over the past day.

Buy or Sell?

Buy

80

TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 1.54% over the past day.

Buy or Sell?

Sell

27

CDNAF alert for Dec 26

Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Emergent BioSolutions, Inc. SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get EBS Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?

Is SentinelOne Stock Undervalued?

Is Broadcom Stock on Sale?

Stock Ideas

Is NVDA Stock a Buy?

Is AAPL Stock a Buy?

Is GOOG Stock a Buy?

Alerts

GLTO alert for Dec 26

TVTX alert for Dec 26

CDNAF alert for Dec 26

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS